Found: 33
Select item for more details and to access through your institution.
Tumor lysis syndrome risk in outpatient versus inpatient administration of venetoclax and hypomethlators for acute myeloid leukemia.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 9, p. 5323, doi. 10.1007/s00520-021-06119-7
- By:
- Publication type:
- Article
Antifungal prophylaxis during 7 + 3 induction chemotherapy for acute myeloid leukemia is associated with improved survival, in a setting with low incidence of invasive mold infections.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapy.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 3, p. e31, doi. 10.1111/bjh.15861
- By:
- Publication type:
- Article
Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 679, doi. 10.1111/bjh.15156
- By:
- Publication type:
- Article
Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomas.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 495, doi. 10.1111/bjh.15224
- By:
- Publication type:
- Article
Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 3, p. 352, doi. 10.1111/bjh.13300
- By:
- Publication type:
- Article
Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 3, p. 300, doi. 10.1111/bjh.12788
- By:
- Publication type:
- Article
Potential biomarkers to detect traumatic brain injury by the profiling of salivary extracellular vesicles.
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 8, p. 14377, doi. 10.1002/jcp.28139
- By:
- Publication type:
- Article
Induction of anti-leukemic responses by stimulation of leukemic CD3+ cells with allogeneic stimulator cells.
- Published in:
- Experimental Hematology & Oncology, 2018, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40164-018-0118-5
- By:
- Publication type:
- Article
Antibiotic use during cytarabine consolidation in acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 1, p. 79, doi. 10.1007/s00277-020-04238-5
- By:
- Publication type:
- Article
Immunotherapy in Acute Leukemias: Past Success Paves the Way for Future Progress.
- Published in:
- Cancers, 2023, v. 15, n. 16, p. 4137, doi. 10.3390/cancers15164137
- By:
- Publication type:
- Article
Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK‐ERK and NF‐κB pathways in a model of chronic myeloid leukemia.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 5, p. 630, doi. 10.1002/1878-0261.12186
- By:
- Publication type:
- Article
Use of bone‐modifying agents and clinical outcomes in older adults with multiple myeloma.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 16, p. 6945, doi. 10.1002/cam4.2591
- By:
- Publication type:
- Article
Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Nonengraftment Haploidentical Cellular Therapy for Hematologic Malignancies.
- Published in:
- Advances in Hematology, 2012, p. 1, doi. 10.1155/2012/784213
- By:
- Publication type:
- Article
Prevalence and Effect on Survival of Pulmonary Hypertension in Myelofibrosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual Disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Mechanisms of Hypercalcemia in Non-Hodgkin Lymphoma and Associated Outcomes: A Retrospective Review.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Dysuria in a Patient With AIDS and Lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Refractoriness to red blood cell transfusion therapy due to hypersplenism.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Cellular immunotherapy for refractory hematological malignancies.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-150
- By:
- Publication type:
- Article
Cellular immunotherapy for refractory hematological malignancies.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Outcomes of lenalidomide‐ or bortezomib‐based regimens in older patients with plasma cell myeloma.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 1, p. 14, doi. 10.1002/ajh.25996
- By:
- Publication type:
- Article
Outcomes of bendamustine- or cyclophosphamide-based first-line chemotherapy in older patients with indolent B-cell lymphoma.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 4, p. 354, doi. 10.1002/ajh.25707
- By:
- Publication type:
- Article
Late infections and secondary malignancies after bendamustine/rituximab or RCHOP/RCVP chemotherapy for B-cell lymphomas.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 1, p. E1, doi. 10.1002/ajh.24921
- By:
- Publication type:
- Article
Primary refractory Hodgkin lymphoma: Limited options and poor survival-but not always.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 8, p. 853, doi. 10.1002/ajh.23660
- By:
- Publication type:
- Article
Thrombosis in COVID 2022: An Updated Narrative Review of Current Literature and Inpatient Management.
- Published in:
- Rhode Island Medical Journal, 2022, v. 105, n. 6, p. 36
- By:
- Publication type:
- Article
Thrombosis in COVID-19: A Narrative Review of Current Literature and Inpatient Management.
- Published in:
- Rhode Island Medical Journal, 2021, v. 104, n. 5, p. 14
- By:
- Publication type:
- Article
Choice of anticoagulation in patients with low risk antiphospholipid syndrome.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2023, v. 56, n. 1, p. 121, doi. 10.1007/s11239-023-02826-6
- By:
- Publication type:
- Article
Ixazomib, Oral Metronomic Cyclophosphamide, and Dexamethasone for First-Line Treatment of Multiple Myeloma: A Phase II Brown University Oncology Group Study.
- Published in:
- Oncologist, 2023, v. 28, n. 5, p. 462, doi. 10.1093/oncolo/oyad017
- By:
- Publication type:
- Article
The return of gemtuzumab ozogamicin: a humanized anti-CD33 monoclonal antibody–drug conjugate for the treatment of newly diagnosed acute myeloid leukemia.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 8265, doi. 10.2147/OTT.S150807
- By:
- Publication type:
- Article
Acquired Syphilis With Anemia and Leukoerythroblastic Reaction: A Case Report.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Seroconversion and outcomes after initial and booster COVID-19 vaccination in adults with hematologic malignancies.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 18, p. 3319, doi. 10.1002/cncr.34354
- By:
- Publication type:
- Article